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ABSTRACT OF THESIS 
 
 
 
 
CEREBRAL ACTIVATION DURING THERMAL STIMULATION OF BURNING MOUTH 
DISORDER PATIENTS: AN fMRI STUDY 
 
 Functional magnetic resonance imaging (fMRI) has been widely used to study 
cortical and subcortical mechanisms related to pain. The pathophysiology of burning 
mouth disorder (BMD) is not clearly understood. Central neuropathic mechanisms are 
thought to be main players in BMD. This study aimed to compare the location and 
extension of brain activation following thermal stimulation of the trigeminal nerve with 
fMRI blood oxygenation level dependent (BOLD) signal. This study included 8 female 
patients with BMD and 8 matched pain-free volunteers. Qualitative and quantitative 
differences in brain activation patterns between the two study groups were 
demonstrated. There were differences in the activation maps regarding the location of 
activation, with patients displaying greater BOLD signal changes in the right anterior 
cingulate cortex (ACC BA 32/24) and bilateral precuneus (p<0.005). The control group 
showed larger BOLD signal changes in the bilateral thalamus, right middle frontal gyrus, 
right pre-central gyrus, left lingual gyrus and cerebellum (p<0.005). It was also 
demonstrated that patients had far less volumetric activation throughout the entire brain 
compared to the control group. These data are discussed in light of recent findings 
suggesting brain hypofunction as a key player in chronic neuropathic pain conditions. 
 
KEYWORDS: Burning Mouth Disorder, Functional Magnetic Resonance Imaging, Brain 
Activation, Trigeminal Thermal Stimulation, Thalamic Hypofunction 
 
 
 
Romulo J.C. Albuquerque, DDS 
July 27, 2004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CEREBRAL ACTIVATION DURING THERMAL STIMULATION OF BURNING MOUTH 
DISORDER PATIENTS: AN fMRI STUDY 
 
 
 
 
By 
 
Romulo Jose Cunha Albuquerque 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reny de Leeuw, DDS, PhD 
Director of Thesis 
 
 
Karen Novak, DDS, MS, PhD 
 Director of Graduate Studies 
 
 
 
 
 
 
 
 
RULES FOR THE USE OF THESIS 
 
 
Unpublished theses submitted for the Master’s degree and deposited in the University 
of Kentucky Library are as a rule open for inspection, but are to be used only with due 
regard to the rights of the authors. Bibliographical references may be noted, but 
quotations or summaries of parts may be published only with permission of the authors, 
and with the usual scholarly acknowledgments. 
 
 
Extensive copying or publication of the thesis in whole or in part also requires the 
consent of the Dean of the Graduate School of the University of Kentucky. 
 
 
A library that borrows this thesis for use by its patrons is expected to secure the 
signature of each user. 
 
  
 
 
 
 
THESIS 
 
 
 
 
 
Romulo Jose Cunha Albuquerque 
 
 
 
 
The Graduate School 
University of Kentucky 
2004 
 
 
 
  
 
CEREBRAL ACTIVATION DURING THERMAL STIMULATION OF BURNING MOUTH 
DISORDER PATIENTS: AN fMRI STUDY 
 
 
 
______________________________________ 
 
THESIS 
______________________________________ 
 
A thesis submitted in partial fulfillment of the 
requirements for the degree of Masters of Science 
at the University of Kentucky 
 
 
 
 
By 
 
Romulo Jose Cunha Albuquerque 
 
Lexington, Kentucky 
 
Director: Dr. Reny de Leeuw, Professor of Dentistry 
 
Lexington, Kentucky 
 
2004 
 
 
 
Copyright © 2004, Romulo J.C. Albuquerque 
 
ACKNOWLEDGMENTS 
 
 The following thesis, while an individual work, benefited from the insights and 
direction of several people. First, my Thesis Committee, Dr. Reny de Leeuw (Thesis 
Chair), Dr. Jeffrey Okeson and Dr. Charles Carlson, exemplifies the high quality 
scholarship to which I aspire. In addition, Anders Andersen and Craig Miller provided 
timely and instructive comments and evaluation for the development of this work. My 
fellow residents, staff from the Orofacial Pain Center and staff from the Magnetic 
Resonance Imaging and Spectroscopy Center (Agnes Bognar, Nancy Bailey and David 
Powell) were indispensable part for the accomplishment of this research. I would like to 
thank the Orofacial Pain Center and the Magnetic Resonance Imaging and 
Spectroscopy Center for having funded this study. In particular, I would like to 
acknowledge my patients and volunteers for their willingness to take part in this study. 
Their role is indisputably vital to the advances that science has undergone throughout 
its history. 
 For my part, I would like to thank Dr. Jeffrey Okeson for having given me the 
opportunity to embark this intellectual journey at the Orofacial Pain Center. I would also 
like to thank my family, who back in Brazil has supported me by all means through this 
academic process.  Above all, this work would not have been possible if it was not for 
my wife Lisandra Garcia. She was my harbor when storms came through. She was my 
friend, my family, my “everything”. I dedicate this thesis to her.  
 
 
 
 
 
 
 
 
 
 
 
iii
TABLE OF CONTENTS 
 
Acknowledgments……………………………………………………………………..………..iii 
 
Table of Contents……………………………………………………………………………….iv 
 
List of Tables……………………………………………………………………………..……..vi 
 
List of Figures………………………………………………………………………..…………vii 
 
List of Files……………………………………………………………………………………..viii 
 
1. Introduction……………………………………………………………………….…………..1 
 
2. Purpose of the Study……………………………………………………………….………..3 
 
3. Review of the Literature……………………………………………………………………..4 
  
3.1. Technical Foundation of Functional Neuroimaging Methods: an Emphasis  
on fMRI……………………………………………………………………………...……4 
 
3.2. PET vs. fMRI…………………………………………………………………..……5 
 
3.3. Functional Neuroanatomy of Pain…………………………………………..……5 
 
3.4. Common Supraspinal Sites Depicted by Neuroimaging Pain Studies…….....7 
 
3.5. Functional Neuroimaging in Chronic Pain………………………………….….15 
 
3.6. Functional Brain Imaging in Orofacial Pain………………………………...….17 
 
3.7. Burning Mouth Disorder………………………………………………………….22 
 
3.8. Hypothesis……………………………………………………………………...…27 
  
4. Materials and Methods…………………………………………………………………..…29 
  
 4.1. Study Design…………………………………………………………………...…29 
 
 4.2. Study Population…………………………………………………………….……29 
 
 4.3. Subject Recruitment Method………………………………………………..…..30 
 
 4.4. Research Procedures……………………………………………………………31 
 
 4.5. Statistical Analysis……………………………………………………………….34 
 
 
iv
 
 
5. Results………………………………………………………………………………….……37 
 
 5.1. Demographics and Psychophysical Tests………………………………..……37 
 
 5.2. Functional MRI Data Analysis……………………………………………..……40 
 
6. Discussion………………………………………………………………………………...…46 
 
6.1. Qualitative Differences in Brain Activation Between Patients and 
Controls……………………………………………………………………………...….47 
 
6.2. Quantitative Differences in Brain Activation Between Patients and     
Controls……………………………………………………………………………...….50 
 
6.3. Future Research Directions…………………………………………………..…54 
 
6.4. Study Limitations………………………………………………………………....55 
 
7. Summary………………………………………………………………………………….…57 
 
References…………………………………………………………………………….…….…58 
 
Vita………………………………………………………………………………………………71 
 
 
 
 
v
LIST OF TABLES 
 
 
Table 1. Detailed description of the patient population ………………………………...…38 
 
Table 2. Comparison between patients with BMD (n=8) and controls (n=8) regarding the 
psychophysical data…………………………………………………………………………...39 
 
Table 3. Comparison between patients with BMD (n=8) and controls (n=8) regarding the 
SCL-90 subscales…………………………………………………………………………..…39 
 
Table 4. Comparison between patients with BMD (n=8) and controls (n=8) regarding the 
BDI and STAI scores………………………………………………………………………….40 
 
Table 5. Areas of differential activation between BMD patients (n=8) and pain-free 
volunteers (n=8)…………………………………………………………………………….….44 
 
Table 6. Location and size of the detected clusters of activity in the patient group…….44 
 
Table 7. Location and size of the detected clusters of activity in the control group…….45 
 
 
 
 
 
 
 
vi
LIST OF FIGURES 
 
Figure 1. Magnetic resonance image of the left anterior cingulate cortex located by the 
Talairach coordinates (x,y,z)=(5[L],27[A],23[S])…............................................................8 
 
Figure 2. Schematic representation of the anterior cingulate cortex and its subdivisions.  
………………………………………………………………………………………………...…..9 
 
Figure 3. Magnetic resonance image of the left insular cortex located by the Talairach 
coordinates (x,y,z)=(34[L],0[A],4[S])…………………………………………………………11 
 
Figure 4. Magnetic resonance image of the left thalamus located by the Talairach 
coordinates (x,y,z)=(9[L],15[P],9[S])…………………………………………………………13 
 
Figure 5. Magnetic resonance image of the left dorsolateral prefrontal cortex located by 
the Talairach coordinates (x,y,z)=(42[L],8[A],29[S])……………………………………….14 
 
Figure 6. Thermal stimulation paradigm (in degrees Celsius)……..……………………..33 
 
Figure 7. Activation map of the BMD group (n=8)………………………………………….41 
 
Figure 8. Activation map of the control group (n=8)………………………………….…….41 
 
Figure 9. Activation map of the comparison between BMD group (n=8) and control 
group (n=8)……………………………………………………………………………………..42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii
LIST OF FIGURES 
 
File 1. ………………………………………………………………………….. fMRI_BMD.pdf 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii
1. Introduction 
 Extensive attention has been given to the understanding of the 
mechanisms involved in nociception, pain modulation and perception by researchers 
and clinicians around the world. At the present time, however, the implications of the 
central nervous system (CNS), especially supra-spinal mechanisms, in chronic pain 
conditions, pain perception and modulation processes are poorly understood.  Most of 
our knowledge is derived from either extrapolations from animal model studies [1, 2] or 
case reports from patients who had different types of injuries, neuropathies, or surgical 
procedures involving the CNS [3, 4] [5, 6]. The use of positron emission tomography 
(PET) and the recent development of functional magnetic resonance imaging (fMRI) 
have added objective knowledge of pain processing and have clarified some of the 
features and implications of the CNS in the complex pain modulation networks.   
 The neural circuits of pain are far beyond a simple nociceptive input barrage 
arising from the periphery to the CNS. Rather, pain processing networks are under the 
influence of several modulating factors that will be elaborated below. Further, the neural 
circuits of pain have different dimensions and aspects as proposed by Melzack [7] in the 
pain “neuromatrix”. These circuits comprise a widely distributed neural network that 
includes parallel somatosensory, limbic and thalamocortical components that enable the 
sensory-discriminative, affective-motivational and evaluative-cognitive dimensions of 
pain experience.  
Functional MRI studies have been performed since Belliveau and colleagues 
published the first paper in 1991. [8] A series of different central processing 
mechanisms have been explored with functional MRI techniques, such as attention and 
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cognition, [9],[10] language, [11] memory, learning, vision processing, auditory 
perception, [12] cerebellum neurophysiology, [13] and sensory and motor functions.  
Functional MRI has also been used in neurosurgical planning and for implantation of 
electrodes within different brain structures for the treatment of neuropathic pain 
conditions. [14]  
 A variety of functional neuroimaging studies have been conducted to clarify the 
role of neural structures and cortical regions implicated in the pain “neuromatrix”.  
Creative, elegant and well-planned research has been designed to explore the 
“neuromatrix” associated with acute pain models (chemical, thermal and mechanical 
stimuli) and clinical pain conditions, such as migraines, [15] cluster headaches [16-19], 
neuropathic pain [20-22] and phantom limb pain. [23] These studies have greatly 
improved our understanding about the role of many CNS structures in the underlying 
mechanisms of the above mentioned clinical pain entities. Other orofacial pain 
disorders, have not yet been the focus of extensive neuroimaging studies. Orofacial 
pain disorders comprise a variety of acute and chronic pain conditions that include, but 
are not limited to temporomandibular joint disorders, masticatory myofascial pain, 
trigeminal neuralgia and continuous neuropathic pains, including burning mouth 
disorder (BMD).  Some of these disorders do not respond to peripheral interventions 
and it is likely that CNS mechanisms are primarily involved in their etiologies. [24]  
Brain-imaging studies are a powerful tool for exploring and understanding more of the 
features of the complex central network of pain in the orofacial region as well as 
exploring the likely pathophysiology of chronic orofacial pain conditions, such as BMD. 
 
Copyright © 2004, Romulo J.C. Albuquerque 
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2. Purpose of the Study 
 
Functional MRI studies investigating stimulation of the trigeminal nerve are 
scarce.  To date, chronic orofacial pain conditions have not been investigated under the 
spectrum of fMRI. This study intends to investigate differences in location and extent of 
activation of brain regions involved in the sensory-discriminative and emotional-affective 
components of trigeminal pain processing between patients with BMD and age-matched 
pain-free volunteers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 2004, Romulo J.C. Albuquerque 
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3. Review of the Literature 
 
 
3.1. Technical Foundation of Functional Neuroimaging Methods: an Emphasis on 
fMRI  
 
 Brain-imaging studies rely on the ability of techniques, such as positron emission 
tomography (PET) and functional magnetic resonance imaging (fMRI), to detect 
“activity” within the central nervous system. This activity is presumably related to 
glucose metabolism (PET) and blood perfusion changes (fMRI) most likely associated 
with neuronal firing [25] [8]. The respective imaging techniques do not directly measure 
neuronal activity, but translate changes in regional blood flow and blood oxygenation 
levels associated with such activity into detectable signals. The most common way of 
detecting brain activity with fMRI is by measuring relative changes in oxyhemoglobin 
and deoxyhemoglobin levels. Thus, blood oxygenation level dependent (BOLD) signals 
are measured in and around the microvasculature of active centers in the CNS.  More 
specifically, oxygenated hemoglobin circulates through the brain capillary network and 
has magnetic susceptibility similar to the surrounding tissues.  When activated, neurons 
extract oxygen from the capillaries, distending the venous vessels and causing 
oxygenated blood perfusion and relative dilution and reduction of deoxyhemoglobin 
concentration.[25] Oxygenated hemoglobin and deoxyhemoglobin have diamagnetic 
and paramagnetic properties, respectively. They serve as a type of endogenous image 
contrast. When the relative concentration of oxyhemoglobin and deoxyhemoglobin 
change, the signal of the T2* weighted MRI changes as well. The local physiological 
changes result in increased magnetic signal and create a brighter image in the area of 
activation. [26] Maps of brain activation are developed by extensive processing and 
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statistical analysis of the acquired images.  Statistical correlations between the BOLD 
signal and the desired study stimuli are then calculated for each voxel of the brain 
image throughout the experiment time.   In summary, neural activity has been linked to 
physiological changes in the local microvasculature that are detectable with imaging 
techniques such as fMRI [8, 27]. 
 
3.2. PET vs. fMRI 
 When compared to PET imaging, functional MRI renders a series of advantages, 
as described by Peyron et al. (2000) [28] For instance, functional MRI has superior 
temporal and spatial resolution; there is no need for radioactive image contrast as is 
needed for PET, and no injection is required. Further, in fMRI, individual subject data 
may be analyzed, in contrast to PET studies, where images require pooling in order to 
achieve interpretable results.  Functional MRI also has some disadvantages when 
compared to PET.  Pulsating artifacts impede a detailed visualization of brainstem and 
thalamic activation.  In addition, fMRI is limited to comparisons of cerebral neuronal 
activation with resting states (baseline activity); and it is therefore unable to portray 
possible certain neuronal events related to, for example, chronic pain states.[28] 
Notwithstanding the differences presented between the two techniques, results from 
both imaging techniques are generally  comparable [29]. 
 
3.3. Functional Neuroanatomy of Pain 
 In order to comprehend the most common findings of fMRI studies, it is important 
to review some of the functional neuroanatomy of the pain-processing network. The 
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conduction of information to the CNS (afferent conduction) is performed by different 
types of neurons: the first-order neurons that conduct the input from the periphery into 
the spinal cord; the second-order neurons, which travel along the spinothalamic 
pathway ascending to the higher centers (thalamus, cortex) of the CNS; and the third-
/fourth-order (interneurons) neurons, which carry impulses through a multi-synaptic path 
to the thalamus, reticular formation, other parts of the brainstem and other brain 
structures, such as the cerebellum, superior colliculus, pontine parabrachial nucleus 
and periaqueductal gray matter. [30] Nociceptive input is just one of the many different 
types of afferent signaling barrages (sensory pathways) ascending to the CNS and it will 
be the main focus of our discussion in this section.   
 The nociceptive conduction process involves two main pathways: the lateral and 
the medial pain system. The lateral pain system, also called the neospinothalamic tract 
mainly relays information to the ventral posterior lateral nucleus, ventral posterior medial 
nucleus and ventral posterior inferior nucleus of the thalamus.  The lateral thalamic 
nuclei project to the primary (SI) and secondary (SII) somatosensory cortices and are 
thought to be implicated in mediating the sensory-discriminative aspect of the pain 
experience.  When the stimulus travels through the lateral pain system, contralateral 
activation of the brain is expected [31, 32].  
The medial pain system, or paleospinothalamic tract, mainly involves medial 
thalamic structures, such as the ventral part of the ventral medial nucleus, the 
ventrocaudal part of the medial dorsal nucleus, the parafascicular nucleus and the 
contralateral nucleus. The medial thalamic nuclei send information to the insula and 
anterior cingulate cortex (ACC) and comprise primarily the affective-motivational portion 
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of the pain experience. The medial pain system possesses spinothalamic and 
spinoreticular projections to various brainstem nuclei and the limbic structures. [33] 
From the limbic system the nociceptive stimulus is conducted to both right and left 
cerebral cortices, expressing most likely, a bilateral activation. A word of caution is in 
place here because there are several additional cortico-cortical connections that may 
also be important in pain pathways.[31] Thus dichotomizing the pain pathways into a 
lateral and medial system is much too simplistic. .   
 
3.4. Common Supraspinal Sites Depicted by Neuroimaging Pain Studies 
Different brain regions have shown activation during acute painful stimulation, in 
terms of functional neural imaging. The meaning of such activation is the center of 
extensive debate. In this section, the most commonly activated brain structures are 
described and the functional relevance of these findings is discussed.  
 
3.4.A. Anterior Cingulate Cortex (ACC) 
The ACC is one of the most commonly investigated brain structures. It is located 
above the corpus callosum (Figure 1), and is one of the many components of the brain 
hemispheres’ medial wall.  In recent studies, the ACC has been divided into two main 
components, based on the cytoarchitecture, organization and function. The two 
components are the anterior or rostral portion (aACC), also called the perigenual 
cingulate, and the posterior or caudal portion (pACC). The pACC is subdivided into a 
dorsal portion and a ventral portion, which is also called the midcingulate region (Figure 
2).[34] [35]  
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Fig 1. Magnetic resonance image of the left anterior cingulate cortex located by the Talairach coordinates 
(x,y,z)=(5[L],27[A],23[S]). 
 
 
 
The ACC has been directly and indirectly related to the neural circuitry of pain.  
There have been reports of ACC involvement in pain, anticipation of pain, [9] anxiety, 
[36] attention and motor responses. [37] It has been suggested that the rostral portion of 
the ACC (perigenual cortex) subserves the affective reaction to pain. In other words, 
activity in the rostral ACC is directly related to the unpleasantness of the stimuli, [38],[6, 
31, 39]. Apparently this region of the cingulate cortex also plays an important role in 
processing anxiety [36] [40]. 
Based on experimental studies in healthy subjects, activity within the ventral 
portion of the pACC (midcingulate cortex) has been linked to thermal painful stimuli. 
Recent evidence supports the hypothesis that the midcingulate cortex possesses pain 
intensity encoding properties. [41] [42] They demonstrated that the midcingulate cortex 
was activated by painful stimuli only and that the amount of activation was proportional 
to the intensity of the painful stimulation. Pain-related motor responses have been 
related to activity in the dorsal subdivision of the pACC. [34]  
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Fig. 2 Schematic representation of the anterior cingulate cortex and its subdivisions.  In blue = anterior 
portion of the ACC (perigenual cingulate), in red and green = posterior portion of the ACC (red = 
midcingulate cortex) 
 
 
The ACC appears to exert a significant role in the pain modulatory system.[10]  
Functional MRI data have shown that the anticipation of a painful stimulus resulted not 
only in activation of the ACC, but also in higher pain ratings that were similar to actual 
painful stimuli. [9]  Another study showed that distraction from a painful stimulus also 
activated ACC neurons, and this correlated with a decrease in the reported pain 
intensity. [34]  These results suggest that the ACC modulatory influence can be either 
inhibitory or excitatory in nature. 
The current literature suggests that the ACC is a major CNS player in chronic 
neuropathic pain conditions. Increased activation of the midcingulate cortex has been 
observed in some neuropathic conditions, [21], or after capsaicin application [43] Due to 
conflicting data in the reports on neuropathic pain conditions, Peyron  [28]  suggested 
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that the level at which the deafferentation occurs (peripheral or central) may influence 
the activity in the midcingulate cortex. This was based on the fact that decreased 
activity in the midcingulate cortex has been shown to occur when an allodynic region is 
stimulated in patients who suffered medullary infarcts. On the other hand, increased 
activity within the midcingulate was demonstrated following stimulation of an allodynic 
area secondary to peripheral nerve lesion. [44]   
Taken together, the functional meaning of ACC activity upon experimental 
stimulation can be very puzzling, since it is very likely that this structure possesses a 
variety of functions within the CNS.[45]  More detailed investigations are warranted to 
further elucidate what the true functional roles of this cortical zone are. 
 
3.4.B. Primary (SI) and Secondary (SII) Somatosensory Cortex  
The primary somatosensory cortex (SI) is located in the postcentral gyrus and 
receives somatosensory input from the ventral posterolateral and ventral posteromedial 
nuclei of the thalamus. The secondary somatosensory cortex (SII) is positioned 
immediately posterior to the SI and constitutes one of the functional components of the 
parietal lobe of the brain. Both SI and SII are limited inferiorly by the Sylvian fissure 
which separates the temporal from the parietal lobe in this specific region. [46]  Despite 
the fact that activation within the SI and SII has been correlated to painful stimulation, 
[47], [48] the functional significance of activation of either region remains to be 
elucidated.  It has been suggested that both regions (SI and SII) are related to encoding 
spatial, temporal and intensity aspects of noxious input, [49] [ Bornhovd, 2002 #384],[50] 
[Peyron, 2000 #60] however, neither one of the somatosensory cortices are solely 
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involved in the interpretation of noxious input because they are activated by innocuous 
sensory stimulation as well. [51] 
  
3.4.C. Insula  
 The insular cortex lies deep beneath the lateral cerebral fissure (Figure 3) and it 
is divided into two different components: anterior and posterior. [46]  The posterior 
portion of the insula is localized in close proximity to the SII, which is why many PET 
studies could not differentiate between activation in the SII and posterior portion of the 
insular cortex. [52]  The insula has been implicated in both affective and sensory-
discriminative aspects of the pain experience. [6], [31], [48] Careful investigation of the 
insular cortex using fMRI indicates that the posterior portion appears to be involved in 
the sensory-discriminative dimension of the pain experience. [37] In addition, it has 
been described as the thermosensory cortex because of its ability to encode thermal 
stimulus intensity. [53] The anterior portion of the insula seems to be a component of 
the affective-motivational aspect of the pain neuromatrix. Activity within this region may 
be affected by attention towards the painful stimuli. [37] 
 
Fig. 3. Magnetic resonance image of the left insular cortex located by the Talairach coordinates 
(x,y,z)=(34[L],0[A],4[S]) 
 
 
 
11
3.4.D. Thalamus 
The thalamus is a component of the diencephalon (Figure 4). Previously, it has 
been described as a relay station located between the spinal cord and the cortex [33, 
54].  The thalamus is an important relay station for both the medial and lateral pain 
system.  With respect to the pain experience, the roles of three thalamic regions have 
been described.  The posterior nuclei are involved in conduction and processing of 
painful stimuli, the ventral posterior nuclei are thought to participate in the localization 
process of the pain stimulation and the medial nuclei are implicated in the affective-
aversive nature of the painful stimuli. [55]  Recent advances in spatial resolution with 
fMRI have made it possible to evaluate the function of the thalamus in a more detailed 
manner. [56]  For instance, thalamic activation has been demonstrated during acute 
phasic heat stimulation. [48, 57]  The thalamus possesses a great number of 
interconnections and inhibitory synaptic networks. Therefore, bilateral activation of the 
thalamus may not only reflect a sensory response, but could be related to the arousal 
reaction induced by the painful stimuli as well. [28]  
Thalamus hypoactivity has been linked to chronic pain conditions [20, 58].  The 
facts that thalamic stimulation can produce analgesia and that thalamic stimulating 
devices have been shown to reduce pain in some neuropathic pain states [59] reinforce 
the premise that decreased thalamic activity may be one of the pathophysiological 
markers for chronic pain. [60] Taken together, these data suggest the thalamus is a 
dynamic CNS structure that relates to the sensory-discriminative and affective-
motivational dimensions of the pain experience. It is also very likely that activity in the 
thalamus is compromised in chronic neuropathic pain conditions.    
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Fig. 4. Magnetic resonance image of the left thalamus located by the Talairach coordinates 
(x,y,z)=(9[L],15[P],9[S]) 
 
 
 
3.4.E. Prefrontal Cortex 
The prefrontal cortex is the most anterior portion of the frontal lobe (Figure 5) and 
comprises Brodmann areas 9 and 10. The prefrontal cortex has several connections to 
other brain structures, such as the dorsomedial nucleus of the thalamus, other cerebral 
lobes and the hypothalamus [61]. The prefrontal cortex presumably plays a crucial role 
in memory retrieval [62] and attention processing in normal individuals, when they 
experience an experimentally induced noxious stimulus [41, 49]. Apparently, the 
prefrontal cortex is activated by painful heat application, but the amount of activation 
does not increase with increased stimulus intensity (on- and off-response). [41, 49] 
Clearly, pain intensity encoding is not a task of the prefrontal cortex. 
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Fig 5 Magnetic resonance image of the left dorsolateral prefrontal cortex located by the Talairach 
coordinates (x,y,z)=(42[L],8[A],29[S]) 
 
 
Prefrontal cortex functioning has been investigated in chronic pain patients. 
Apkarian et al [22] reported that in the sympathetically maintained pain state, subjects 
display prefrontal hyperactivity in response to painful stimuli that could be reversed after 
pain blockade. Hsieh et al. [21] also found increased activity in parietal and prefrontal 
cortices in chronic neuropathic pain patients. Hence, the prefrontal cortex may play an 
important role in the pathophysiology of some chronic pain conditions. 
 
3.4.F. Other Brain Regions 
 Several studies demonstrated activation of other brain structures such as the 
inferior parietal cortex, cerebellum and amygdala during painful stimuli. These brain 
areas were not always consistently activated and the functional significance of their 
activation within the pain neuromatrix is even less understood than the previously 
discussed brain structures. [31, 43] [41, 63] 
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3.5. Functional Neuroimaging in Chronic Pain 
 As previously mentioned, there are few neuroimaging studies of chronic pain 
conditions. In this section, these studies are discussed in a more detailed manner, since 
they are important to the development of the present study’s hypothesis. 
Iadorola et al. [20] studied 5 patients with chronic neuropathic pain with oxygen-
15 water bolus PET. Four of these patients had pain confined to one lower limb and one 
patient had ophthalmic post-herpetic neuralgia. The authors found that, in patients, 
thalamic activity on the side receiving input from the symptomatic limb was decreased 
compared to activity on the side receiving input from the asymptomatic limb and 
compared to activity generated in control subjects. The decrease in thalamic activity 
was most robust in anterior dorsal and posterior ventral regions. Earlier, Di Piero [58] 
who studied 5 cancer pain patients with PET found contralateral decrease in thalamic 
activity as well, and also found this in posterior and anterior nuclei. Di Piero [58] and 
Iadorola [20] suggested that decreased thalamic activity may be a clinical feature 
common to a wide variety of chronic pain disorders. It has been postulated that these 
changes in thalamic activity may lead to a loss of central inhibition.   
Using fMRI, Apkarian et al. (2001) studied 7 subjects with unilateral 
sympathetically maintained pain limited to one hand before and after the SMP was 
suppressed by sympathetic blockade. [22] In the clinical pain state, the subjects showed 
increased prefrontal activity, and decreased parietal cortical and contralateral thalamic 
activity in response to an additional painful stimulus. These activation patterns were 
reversed after pain was eliminated by a sympathetic block (bupivacaine 0.2%).The 
authors concluded that the altered activation patterns within the prefrontal and parietal 
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cortex and the thalamus may play a crucial role in the pathophysiology of 
sympathetically maintained pains.  
 A similar study was previously done by Hsieh et al. [21] who studied 8 chronic 
neuropathic pain patients before and after regional nerve block with PET. During the 
clinical pain status, they found increased activity in bilateral insula, parietal and 
prefrontal cortices and posterior cingulate and right anterior cingulate (BA24) regions. 
They also noted decreased activity in the contralateral posterior thalamus. No 
differences were found in the activity of SI and SII regions as it related to the pain status 
before and after regional nerve block. These findings suggest that abnormal brain 
responses may underlie sympathetically maintained pain and that prefrontal/limbic 
networks may be extensively involved.  
Gracely et al. [64] conducted an fMRI study whereby 16 fibromyalgia patients 
were compared to 16 gender and age matched healthy controls. They reported their 
results in terms of number of activated clusters for each group. For the same subjective 
experience of pressure induced pain they found 19 regions of increased regional 
cerebral blood flow in healthy controls and 12 regions of increased regional cerebral 
blood flow in fibromyalgia patients. There were 7 regions common to both groups. 
Statistical comparison between the two groups revealed 13 regions with higher 
activation in the patient group. Their results strengthen the hypothesis that fibromyalgia 
is a cortical or subcortical pain augmentation disorder. A similar study [65] also found 
that chronic low back pain and fibromyalgia patients display more extensive common 
patterns of activation when compared to normal volunteers. Together, these studies 
also corroborate with the augmented central pain processing theory.[64, 65] 
 
 
16
In summary, the available neuroimaging studies seem to suggest that alterations 
in brain activation patterns are consistent findings in chronic pain patients. These 
alterations have been observed not only when comparing patients to controls, but also 
when comparing patients during the painful state and a pain-free situation. The ACC, 
thalamus and prefrontal cortex seem to be areas where these alterations primarily 
occur. Nonetheless, one has to take into account that the reported studies involve 
different methods and heterogeneous clinical pain conditions. 
 
3.6. Functional Brain Imaging in Orofacial Pain 
 Craniofacial pain conditions, such as masticatory muscle pain, TMJ pain, dental 
pain, trigeminal neuralgia, burning mouth disorder and migraines are mediated by the 
trigeminal nerve (CNV).  The CNV possesses unique brainstem mechanisms and 
nociceptive transmission characteristics. The CNV has a unique somatotopical 
organization, as it relates to a group of nuclei at the brainstem level: the trigeminal 
spinal tract nucleus, the main sensory nucleus and the trigeminal motor nucleus.[30] 
The trigeminal nerve also has distinctive macroscopic anatomical characteristics, such 
as the intracranial location of the trigeminal nerve ganglion and its relationship to 
adjacent structures. These peculiar features of the CNV may account for significant 
differences in the central neural network of trigeminal pain versus pain in the rest of the 
body. 
 Brain imaging studies have been used to explore the pain “neuromatrix”. 
However, few studies focused on the central pain network related to activation of the 
trigeminal nerve.  With regard to the CNV, most of the functional brain imaging studies 
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were primarily intended to gain insight in the pathophysiology of headache disorders, 
such as cluster headache, [16] SUNCT (short lasting neuralgiform headache with 
conjunctival injection and tearing) [66] and migraine. [67, 68]  Thus, so far, the available 
studies have focused mainly on midbrain, pons and hypothalamic grey activation 
evoked by input from the ophthalmic nerve branch (CNV1) of the CNV and the possible 
role of these areas as neurovascular pain generators.   
Derbyshire et al. (1994) investigated patients with “atypical facial pain” with PET. 
However, the actual painful and non-painful thermal stimuli were applied on the back of 
the right hand.  They reported an increased regional cerebral blood flow (rCBF) in the 
ACC and decreased blood flow in the prefrontal cortex and hypothesized that this 
pattern of activation may compromise central inhibitory influences towards the 
nociceptive input therefore contributing to the maintenance of the pain condition. [69]  
Kupers et al. (2000)[59] presented a PET study whereby a single patient 
suffering from atypical facial pain was successfully treated with a thalamic stimulator. 
They were able to perform functional imaging of the patient during three different states: 
before thalamic stimulation (pain state), during and after thalamic stimulation (pain-free 
states). By comparing the pre- and post-thalamic stimulation status they found that 
there were significant rCBF increases in the prefrontal and anterior insular cortices, 
hypothalamus and periaqueductal gray that were related to the presence of pain. 
Interestingly, there were no significant rCBF changes observed in thalamus, SI, SII and 
ACC. Significant rCBF decreases were observed in the substantia nigra/red nucleus 
and in the anterior pulvinar nucleus. The authors discussed their data emphasizing 
possible differences in the cerebral processing of acute and chronic pain, however their 
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results need to be analyzed with caution since it reflects measurements of a single 
individual. Thayer and Friedman (2002) commented on the role of such central 
networks in light of maladaptive behaviors or brain states, which they contributed to 
dysfunctional inhibitory processes. They argued that dysfunction in CNS regions could 
lead to “disinhibition”, which would prohibit adaptability to normally innocuous stimuli 
[70].  
More recently, Kupers et al. (2004)[71] have carried out a PET study that 
investigated the cerebral activation network related to experimental masseter muscle 
pain and skin hyperesthesia overlying the painful muscle. They reported that painful 
stimulation of the masseter was related to increased rCBF in the dorsal-posterior insula, 
ACC, prefrontal cortex, right posterior parietal cortex, brainstem, cavernous sinus and 
cerebellum. They also found that there were no rCBF changes in the SI and SII, 
however, mechanical stimulation of the skin overlying the masseter muscle was 
associated with increased rCBF of the SI face representation. Hyperesthesia was also 
associated with rCBF increases in the subgenual cingulate and ventroposteromedial 
and dorsomedial thalamus. Based on their findings they stated that deep muscle pain 
and superficial cutaneous stimulation may possess a different CNS representation.  
Differentiation of deep visceral and cutaneous pain in human brains has also 
been demonstrated by Strigo et al. (2003)[72]. The authors implied that different 
patterns of activation within insular, SI, motor, and prefrontal cortices may account for 
the ability to discriminate visceral and cutaneous pain. They also stated that the 
different emotional, autonomic and motor responses associated with these different 
sensations may account for the observed different pattern of activation.  
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Functional MRI data of brain activation produced by stimulation of different 
branches from the CNV, other than V1, are scarce.  It is largely unknown whether the 
CNS network of connections related to trigeminal input is similar to the areas activated 
by stimulation in other areas of the body, such as the extremities.  De Leeuw et al. 
studied fMRI BOLD changes in different brain regions following acute phasic heat 
stimulation of the V3 branch in normal subjects, and found that heat stimulation of the 
trigeminal system resulted in activation of brain regions similar to those reported in 
studies of peripheral body parts. [73] DaSilva et al. [74] have also explored activation of 
CNS regions created by thermal stimulation of the trigeminal system in healthy subjects. 
They focused their analysis on the somatotopic arrangement of the three trigeminal 
branches in the trigeminal spinal tract nucleus, thalamus and somatosensory cortex. 
Contralateral activation of ventroposteromedial thalamic nucleus was observed after 
CNV stimulation, as opposed to contralateral ventroposterolateral nucleus activity 
displayed when the thumb was stimulated. They also reported that SI activation pattern 
was similar to the trigeminal spinal tract nucleus laminar organization (V2 rostral, V1 
caudal and V3 medial) and that this activity pattern in SI was not the same as the one 
created by the stimulation of the ipsilateral thumb.  
 Iannetti et al. [75] investigated the representation of the different divisions of the 
trigeminal nerve within SI and SII in humans using non-painful mechanical tactile 
stimulation. They mechanically stimulated the ophthalmic and mandibular trigeminal 
branches of 14 healthy individuals and encountered contralateral activation of SI and SII 
that largely overlapped. They also found that while V3 stimulation activated the 
contralateral somatosensory cortices alone, V1 stimulation provoked activation in the 
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ipsilateral and contralateral sides of SI and SII. This study illustrated some of the distinct 
cortical representations inherent to the trigeminal nerve. It is important to notice that 
these authors were only investigating tactile cortical representation of the trigeminal 
nerve and not pain. 
 Functional MRI has also been used to locate and identify brainstem and cervical 
spinal cord nuclei that are related to cranial nerves sensory and motor pathways.  In an 
fMRI study, Komisaruk et al. [76] used cross-correlation analysis of regional blood 
oxygen level-dependent (BOLD) signal intensity during specific motor and sensory 
procedures such as brushing the face, left- and right eye movement, smiling and lip 
puckering, pushing the tongue against the hard palate, swallowing, tasting a sweet-
sour-salty-bitter mixture, finger tapping and tongue movement and trapezius muscle 
activation. They were able to locate the brainstem trigeminal main sensory nucleus 
among other cranial nerves nuclei. Painful stimulation was not investigated in this study.  
 In summary, data from the above mentioned studies suggest that in orofacial 
chronic pain states (atypical facial pain) it seems like the finding of a dysfunctional brain 
network is also observed. The thalamus, prefrontal cortex and ACC appear to be the 
major players in such dysfunction. During thermal acute pain stimulation it is possible 
that the trigeminal nerve possesses unique thalamic transmission pathways with 
activation of the ventroposteriormedial nucleus instead of the ventroposteriorlateral 
nucleus. 
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3.7. Burning Mouth Disorder 
 Burning mouth disorder (BMD) is defined as an idiopathic, constant, most 
commonly bilateral, burning sensation involving intra-oral soft tissues (tongue, lips and 
oral mucosa).[77, 78]  According to epidemiological studies its prevalence in the general 
adult population is estimated to be between 1 and 3% [79, 80]. In the United States 
more than 1 million people suffer from BMD. [81] Clinical studies indicate that post-
menopausal females are more frequently affected by BMD [82]. For a complete review 
of BMD epidemiology and clinical characteristics refer to Fraikin et al. [83], Grushka et 
al. [78], Scala et al. [84] and Rhodus et al. [85] 
 It has been proposed that a distinction should be made between BMD and oral 
burning. Whereas the term burning mouth disorder refers to an idiopathic burning of the 
intra-oral tissues, the term oral burning has been suggested to imply that the burning 
sensation is secondary to certain pathological states. These pathological states include 
diabetes mellitus [79, 86], xerostomic drugs, nutritional deficiencies, salivary gland 
pathology, mucosal pathology (candidiasis, lichen planus, geographic tongue), gastric 
esophageal reflux and parafunctional habits. Rhodus et al. [85, 87] suggest that the 
treatment of oral burning complaints should aim at identification and management of 
possible contributing/precipitating factors as the ones listed above. After ruling out any 
contributing factors, or in the absence of a positive response of the burning complaint to 
management of these contributing factors, one should consider the possibility of an 
idiopathic condition and therefore name it, more appropriately, BMD. Other authors 
have proposed the classification of burning mouth syndrome as being either primary or 
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secondary in light of its relationship to the same etiological issues mentioned above. 
[84] 
 The lack of consensus with regard to a clear definition of what is generally called 
BMD makes it extremely difficult to review and interpret the results of studies about this 
condition. A good illustration of such difficulties is the fact that some authors [88, 89] 
believe that dysgeusia and xerostomia are concomitant findings and symptoms of what 
they call burning mouth syndrome. Alternatively, other researchers believe that these 
factors may have a causal relationship with the complaint of burning in the oral cavity. 
This relationship, however, is not well understood and can only be established by long-
term studies that evaluate for instance, whether pain reduction or elimination has any 
impact on the dysgeusia and xerostomia or vice-versa.  
 The view that BMD is primarily a psychogenic disorder has lost support as a 
result of recent studies.[90] It is a common observation that depression and anxiety 
disorder are very frequently reported by patients with chronic pain conditions.[91, 92] Eli 
et al. [93] have demonstrated that despite of their elevated psychological profile, BMD 
symptoms may not be correlated with stressful life events. In fact, Carlson et al. did not 
observe any significant clinical elevations on any of the SCL-90R subscales, including 
depression, anxiety, and somatization in a sample of 33 BMD patients. Great 
controversies still exist about the psychogenic factors and how they relate to BMD. 
Interestingly, several studies indicate that the psychological profile abnormalities may 
relate to the patients’s poor coping skills regarding their pain condition. [94, 95] 
The pathophysiology of BMD is largely unexplained. Yet several reports in the 
literature suggest that BMD is likely a neuropathic pain condition. The first line of 
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evidence supporting this hypothesis comes from the clinical trials that demonstrate 
therapeutic effects of anti-epileptic agents, such as clonazepam [96-98] for BMD. 
Secondly, sensory abnormalities have been shown to exist in patients suffering from 
BMD. Svensson et al.[99] stimulated the intra- and peri-oral tissues with an argon laser 
and showed that thermal sensory thresholds were higher in BMD patients.  They also 
reported that stimulation at sensory threshold levels frequently created a faint pinprick 
sensation in patients while normal subjects only described a perception of warmth. Ito et 
al. [100] have also found higher thermal pain thresholds in patients with BMD.  Grushka 
et al. [101] did not observe differences in thermal pain thresholds but they reported that 
patients with BMD had decreased pain tolerance to thermal stimulation. Gao et al. [102] 
showed abnormal sensory function in patients with BMD following electrical stimulation 
of the tongue. All of these studies share the opinion that BMD is very likely a 
neuropathic pain condition as it may represent abnormal transduction and/or processing 
of input arising from the trigeminal afferent fibers to the CNS.  
Nevertheless, to date there is still a great deal of controversy regarding the 
likelihood that BMD is a neuropathic disorder. Moreover, some authors appear to 
implicate peripheral neuropathic pathophysiological mechanisms [88, 89, 102-107], 
while others believe that central neuropathic mechanisms are main players in 
BMD.[108-112] The upcoming section will discuss the studies implicating peripheral and 
central mechanisms in more details.  
Proponents of a peripheral pathophysiology 
Grushka et al. [88] suggested that BMD may be related to selective damage to 
the chorda tympani and glossopharyngeal nerves (sensation of taste). They 
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hypothesized that this deafferentation may result in a loss of inhibition to pain that 
ultimately leads to BMD. Nagler and Hershkovich [89] performed a taste and salivary 
analysis in BMD patients and normal controls. They observed sialometrical and 
sialochemical discrepancies between the control and the patient groups. In light of their 
findings, they proposed that an oral neuropathy or neurologic transduction interruption 
secondary to salivary compositional changes might be an etiological factor in BMD. Gao 
et al. [102] demonstrated increased trigeminal nerve sensitivity and alterations in neural 
transmission within the peripheral nervous system. Lauritano et al. [103] demonstrated 
the existence of subclinical polyneuropathy in 50% of patients with BMD. In particular, 
they detected a loss of function in small diameter nervous fibers. Histological 
examination of tongue mucosa revealed a moderate atrophy in 70% patients. Heckman 
et al. [104] also demonstrated disturbances in oral mucosal blood flow in patients with 
BMD that would support the peripheral pathophysiology hypothesis. Additional support 
for this hypothesis comes from clinical trials supporting the use of alpha-lipolic acid for 
burning mouth disorder. Alpha-lipolic acid is a potent antioxidant mitochondrial 
coenzyme that has shown to posses neuroprotective function.  The use of alpha lipolic 
acid is though to increase the levels of intracellular glutathione and eliminate free 
radicals possibly produced by the altered peripheral nerve fibers. [105, 106, 113] 
Proponents of a central pathophysiology 
Central nervous system mechanisms involved in the pathophysiology of BMD 
have been carefully investigated by a group of researchers from Finland. These authors 
provided preliminary data implicating the CNS in the pathophysiology of BMD. 
Jaaskelainen et al. [108] showed that BMD patients displayed blink reflex abnormalities. 
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They hypothesized that the abnormal reflexes could be due to a decreased 
dopaminergic inhibition mediated by the basal ganglia and their connection to the facial 
motor nuclei. To further test their hypothesis, they performed a fluorodopa-PET study in 
10 BMD patients and 14 normal volunteers. [109] They demonstrated that BMD patients 
had a dysfunction of the nigrostriatal dopaminergic system which confirmed their 
neurophysiologic observations. These investigators also compared 10 BMD patients 
with 11 healthy volunteers to explore differences in the striatal dopamine D1 and D2 
receptors with PET. This study revealed a bilateral decrease in the D1/D2 ratio in the 
putamen. According to the authors, this possibly reflects a decline in endogenous 
dopamine levels in BMD patients.[111]  Similar results were observed by the same 
researchers in patients with atypical facial pain. [110] Hence, the authors discussed the 
contention that disruption of the nigrostriatal dopaminergic system may primarily affect 
the regulation of nociception of the trigeminal system and cause a loss of sensory 
inhibition. These findings are in agreement with experimental data suggesting a role for 
the basal ganglia in the various dimensions of the pain experience.[114] Based on their 
preliminary results, the above mentioned group of authors developed a more robust 
investigation with 52 BMD patients. For this larger trial, they used quantitative sensory 
tests (QST) and blink reflex recordings to investigate the neural mechanisms of BMD 
related pain.  Abnormal findings, such as, increased excitability of the blink reflex and 
abnormal sensory thresholds (warm allodynia or hypoesthesia) were recorded in the 
great majority of patients. The authors felt that their data strengthened the hypothesis 
that BMD disorder is a neuropathic condition and very likely a combination involving a 
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peripheral neurogenic mechanism(s) and an increased excitability of higher centers 
within the CNS.[112] 
In summary, the available literature suggests that BMD is a neuropathic entity 
with peripheral and central neural pathophysiology. It is important to recognize that 
these mechanisms need further elucidation. The only available neuroimaging data to 
date comes from one PET study implicating basal ganglia nuclei in the pathophysiology 
of BMD.[109] It is not known whether other CNS sites are also implicated in 
pathophysiology of BMD.  Functional MRI studies of BMD are an unexplored field of 
investigation.  In general, fMRI studies have provided a significant improvement in the 
understanding of pain-related CNS functioning and appear to be a promising modality 
for the investigation of disorders in which CNS mechanisms are potentially involved.  
 
3.8. Hypothesis 
 
Since we believe that BMD is in fact a painful neuropathy with substantial 
involvement of the CNS in its pathophysiology, we hypothesize to demonstrate 
increased BOLD signal intensity as well as larger clusters of activity within the ACC, and 
decreased BOLD signal intensity and smaller clusters of activity involving the thalamus 
in BMD as compared to the normal volunteers.  In other words, we expect to 
demonstrate that BMD patients have similar brain activation patterns to those observed 
in previous neuroimaging studies pertaining patients with chronic neuropathic pain 
conditions. These studies demonstrated somewhat consistent altered patterns of brain 
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activation that are likely related to the chronic neuropathic pain condition.[115], [116], 
[21], [20], . [58] [59].  
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4. Materials and Methods 
4.1. Study Design:  
 The study is a block design fMRI study, consisting of eight female patients with 
burning mouth disorder (BMD) and a control group of eight normal subjects.  
4.2. Study Population: 
Participants were eight right-handed female patients, who were diagnosed with 
burning mouth disorder and eight right-handed control subjects matched by gender, age 
and menstrual status.  The age matching procedure consisted of recruiting subjects 
within a maximum of five years age difference. The criteria for diagnosis of BMD were 
an at least 3 months old history of an idiopathic burning sensation of the intraoral soft 
tissues. All patients were previously screened for a variety of disorders that may 
account for burning of the intra-oral soft tissues. Exclusion criteria included patients with 
candidiasis, nutritional deficiencies, salivary flow disturbances, lichen planus or 
geographic tongue. Patients who were taking xerostomic medications and angiotensin 
converting enzyme (ACE) inhibitors were excluded, if a positive relationship was 
clinically established between the use of the drug and the intra-oral burning. [87] [87] 
We chose 8 subjects in each group because, as a general rule, results in fMRI 
studies do not seem to improve beyond 10 to 12 subjects. With 10 subjects, the 
variance and heterogeneity of subjects (the noise) increases faster than the additional 
signal. Activation maps from a previous study [73] with nine subjects showed regions 
that were activated with t values ranging from t= 3.7 to t=6.62 at sites of peak activation. 
These values correspond approximately to p values < .0001 and the activations were in 
regions where an effect was predicted (thalamus, insula, PFC, ACC, SI).  Becerra and 
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co-workers [48] studied two groups of eight subjects who underwent identical 
stimulation protocol to evaluate reliability and consistency. They found no significant 
differences in activation between the two groups. Furthermore, the power of fMRI 
studies not only depends on the number of subjects, but also on the number of 
measurements during each scan. Each scanning session includes 128 consecutive MRI 
signal measurements in which the signal intensity is recorded for each volumetric 
(3.5mmX3.5mmX3mm) space of the brain over time.  
Female patients were chosen as the study population to decrease the amount of 
variability in fMRI signaling within the subjects. It is not well known how gender might 
affect fMRI signal. It is also noteworthy that BMD is significantly more prevalent in 
females with a male/female ratio of 6:1[79] [80] [78]. 
We chose to include only right-handed persons to reduce further potential 
heterogeneity of the sample. In general, left-handed people seem to have a less 
pronounced cerebral functional and anatomical asymmetry than right-handed people. 
[117, 118],[119] 
4.3. Subject Recruitment Method: 
The patients were recruited from the Orofacial Pain Center of the University of 
Kentucky.  Participants had to be native speakers of American English, have pain for 
more than 3 months and have burning pain levels above or equal to 3/10 where “0” 
represents no burning pain and “10” represents the most extreme burning pain.  
Patients with present neurological, psychological and chronic pain conditions, other than 
the burning mouth disorder were excluded. The patients were asked to discontinue any 
medications that could potentially affect brain function, such as anti-depressants, 
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anticonvulsants, antipsychotics and analgesics for at least 4 half-lives prior to the 
scanning session. All patients were instructed to withdraw from caffeine on the day of 
the scanning session. Patients who felt that they could not discontinue their medications 
or caffeine were excluded from the study.  The normal volunteers (control group) were 
recruited by flyers that were posted throughout public areas of the University of 
Kentucky campus. All participants were paid US$ 50.00 for their participation. This 
study was approved by the Office of Research Integrity from the University of Kentucky. 
4.4. Research Procedures: 
4.4.A. Pre-fMRI Assessments 
4.4.A.1. Psychometrics. 
Patients and normal volunteers completed a battery of psychometric 
questionnaires, consisting of the Symptom Check List-90 (SCL-90R), Beck Depression 
Inventory (BDI) and the State-Trait Anxiety Inventory (STAI). The SCL-90R is a 90-item 
self report questionnaire that yields nine symptom dimensions and 3 global indices of 
functioning. It is a measure of current symptom status.  It has reliability coefficients 
ranging from r's=0.77-0.90 for the symptom dimensions.  Measures of psychological 
status included the somatization, obsessive-compulsive, interpersonal sensitivity, 
depression, anxiety, hostility, phobic anxiety and paranoid ideation subscales of the 
SCL-90R.  Average scores for each subscale were obtained according to instructions 
outlined in the scoring manual. [120] The BDI [121] is a 21-item self report questionnaire 
that measures cognitive, affective, somatic and vegetative symptoms of depression. 
The BDI has shown strong internal consistency (α between .81 and 88) and is widely 
used in clinical and non-clinical samples [122, 123] The STAI [124] is a 40-item self 
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report questionnaire that measures state and trait anxiety using a 4-point scale ranging 
from “almost always” to “almost never”. This instrument also has shown good internal 
consistency (α between .90 and .93).  
4.4.A.2. Thermal Thresholds and Stimulus Protocol 
Subjects were pre-exposed to the thermal stimuli sequence used in the fMRI 
session. First, pain thresholds were determined with the method of limits. [125]  
Threshold measurements were taken with a Peltier thermode (30 x 30 mm), which was 
positioned on the skin overlying the right masseter.  When necessary, the stimulus 
temperature for heat pain was adjusted, so that the participant rated the painful stimulus 
at least “3 out of 10”, but not higher than “8 out of 10” where “0” meant no pain and “10” 
represented the worst imaginable pain. This was done to assure that the test protocol 
elicited pain, but not to an extent that would incur movement of the participant. The 
baseline adaptation temperature was set at 32°C in accordance with several previous 
publications. The thermal test sequence, as used in the scanner, started with a 35-
second period of a 32°C baseline temperature, followed by a 35-second period of warm 
(39.5°C) non-painful stimulation. After these non-painful temperatures, pulses of painful 
heat (47-49°C) were delivered during a 35-second period. After a sequence of painful 
stimuli, the thermode was brought back to adaptation temperature (32°C) for 35 
seconds (Figure 6). Four of these sequences of baseline, warm and painful stimulation 
formed a complete thermal cycle. The stimulus temperatures were well below the limits 
of potentially tissue damaging temperature ranges. The patients were also instructed to 
grade on a scale from 0 to 10 how much burning they were experiencing (present 
burning index - PBI) right before engaging in the MRI scanning session. 
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Figure 6 Thermal stimulation paradigm (in degrees Celsius) 
 
4.4.B. Functional MRI Session Protocol  
After the participants had completed the pre-fMRI test sequence described 
above, they were guided to the MRI scanner (1.5 Tesla vision system, Siemens, 
Munich, Germany).  The fMRI session allowed for the collection of three-dimensional 
MPRAGE structural images for co-registration of fMRI data with anatomy, that enabled 
the transformation to standardized stereotaxic coordinates [61]. Functional MRI data 
were collected from 44 contiguous 3 (mm) thick axial slices beginning at the level of the 
inferior portion of the cerebellum and yielding whole-brain coverage. A gradient echo 
EPI sequence with TE= 45 (ms), TR= 4.0 (s), and FA=90o was used for functional 
imaging. The in-plane resolution was 3.5 (mm) x 3.5 (mm) with an image size of 64 x 64 
pixels for a field of view of 228 (mm). Magnetic field homogeneity, particularly at the 
base of the brain, was carefully optimized using the field mapping and correction 
facilities of the VISION system (MAPSHIM). Following the anatomy scan, the fMRI 
session for each participant involved two complete thermal cycles in which stimulation 
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was delivered to the left side of the face in a blocked design with alternating epochs of 
baseline, warm, and noxious heat.  
Immediately after the fMRI session, patients were asked to grade the pain levels 
elicited by the thermal painful stimulation on their face on a scale from “0” (no pain) to 
“10” (most extreme pain). Our goal was to produce a similar subjective experience of 
pain in both groups.  
4.5. Statistical Analysis 
4.5.A. Psychometric and Demographic Data Analysis 
 In order to detect possible significant differences between the patients and 
individuals from the control group regarding the psychometric tests and demographic 
information we performed an independent sample t-tests. It is important to note that the 
primary objective of this study was to investigate differences in brain activation patterns 
with fMRI and not to investigate psychometric or demographic differences. However, if 
present, observed discrepancies would need to be taken into account in the 
interpretation of our results 
4.5.B. Functional MRI Data Analysis  
The statistical analysis was carried out with the Analysis of Functional 
Neuroimaging Software (AFNI). The functional images were corrected for motion 
artifacts with automated motion correction software (MATLAB and SPM99). [126]. The 
three-dimensional MPRAGE structural images were transformed into Talairach 
coordinates on an individual basis using AFNI Software. The anterior commissure (AC), 
posterior commissure (PC) as well as two midsagittal points were used to align the 
individual brains at the AC-PC plane. Other landmarks, such as most anterior, posterior, 
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superior, inferior and lateral points of the brain were also used in the Talairach 
transformation process.  
The EPI sequences consisted of 128 full brain images that were acquired in a 
timely manner.  This means that every four seconds a full brain functional image was 
obtained. The 128 time points of the EPI sequences were then correlated with a time 
course box car reference function (.1D files). The reference profiles were designed 
appropriately so as to set up contrasts for the separate comparison of baseline 
temperature vs. warm temperature, baseline temperature vs. pain temperature and 
warm temperature vs. pain temperature.  Thus, activation maps were calculated on a 
voxel-by-voxel basis for each of the three pairings of stimulus conditions in a particular 
run.  Statistical parametric maps based on the mean fractional signal change and 
sample variance within each run were transformed and resampled by cubic spline 
interpolation as isotropic 2 mm voxels in the standard stereotaxic space of Talairach 
and Tournoux [61] using the AFNI software package [127] and spatially smoothed in 
MATLAB 5 (The MathWorks, Natick, MA) using an isotropic Gaussian spatial filter with 
sigma equal to 3 millimeters. Functional data were then merged across runs and across 
participants using the 3dmerge AFNI auxiliary software to generate average group 
activation maps for each pairing of stimulus conditions. Activation maps were created 
for each study group (patients and control subjects). Comparisons between the warm 
(39.5 oC) versus painful heat (47-49 oC) status were used for the construction of the 
statistical maps in each group. This is because the aim of the study is to compare 
supra-spinal mechanisms as it relates to painful stimulation in BMD patients versus 
normal individuals. We believe that by comparing warm to painful heat we construct 
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brain activation maps that relate to painful stimulation alone and not to the processing of 
a warm stimulus or a temperature change. It is also important mentioning that this 
research method is a block design fMRI study.  As such, painful heat stimulation was 
always preceded by warm stimulation.   Maps of the difference in activation between 
patient and control groups were created using an AFNI auxiliary program 3dttest, which 
allows for the execution of independent samples t-tests on a voxel-by-voxel basis for the 
two sets of fMRI three-dimensional data sets.  
A cluster analysis for each of the two groups was performed with the use of 
3Dcluster and 3dclust AFNI auxiliary software. The cluster analysis allowed us to 
measure the total volume of activation throughout the entire brain. Clusters of activity of 
at least 1000 µl of volume and connectivity radius of 2mm were shown in the maps.  
The Talairach coordinates for the center of mass and the location of each cluster were 
recorded and used for comparison between the two groups. For didactic purposes the 
differences regarding the magnitude of fractional signal changes throughout different 
areas of the brain (3dttest) were reported as qualitative differences and the difference in 
the amount of total brain activation (cluster analysis) were regarded as quantitative 
differences.  
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5. Results 
5.1. Demographics and Psychophysical Tests 
 This study included eight BMD female patients (mean age 49.1 ± 10.1) and eight 
pain-free female volunteers (mean age 50.3 ± 12.3) matched with regard to age, and 
menstrual or menopausal status. Six out of the eight patients were post-menopausal 
and two patients still had a regular menstrual cycle. The two patients and two controls 
with a regular menstrual cycle underwent MRI scanning during the low estrogen phase, 
two days following the onset of menses. There were no significant differences between 
the two groups regarding age (p=.845). The BMD patients reported a mean present 
burning index of 4.3 ± 2.1 on a scale from “0” (no burning) to “10” (most extreme 
burning). The mean duration of the BMD was 60.5 ± 38.4 months.  A detailed 
description of the patient population is shown in Table 1. 
There were no significant differences between the two groups related to thermal 
pain thresholds, the pre-fMRI pain rating, the test temperature applied during the fMRI 
session, and the post fMRI pain rating. The pain ratings were measured on a scale from 
“0” (no pain) to “10” (most extreme pain)(Table 2).  
 The psychometric tests revealed significant differences between the two groups 
regarding the SCL-90 subscales for somatization, interpersonal sensitivity and anxiety. 
The other SCL-90 subscales did not differ between groups (Table 3). There were no 
differences in the BDI and STAI (Table 4). 
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Table 1. Detailed description of the patient population 
Patient # Age [yrs.] 
Pain 
Duration 
[months] 
Location 
of Pain PBI 
Menstrual 
Status HRT 
1 41 60 Tongue and Palate 7 PM No 
2 71 120 
Gingival 
and 
Buccal 
Mucosa 
4 PM No 
3 47 60 
Gingiva 
and 
Buccal 
Mucosa  
3 PM No 
4 49 36 Tongue and Palate 8 PM No 
5 42 36 
Gingiva 
and 
Buccal 
Mucosa 
3 PM Yes 
6 55 118 
Tongue 
and 
Buccal 
Mucosa 
3 PM No 
7 40 24 
Tongue 
and 
Buccal 
Mucosa 
3 Regular No 
8 48 30 Tongue and Palate 3 Regular No 
Mean 
(SD) 
49.1   
(10.1) 48 - 4.3 - - 
PBI = present burning index on a scale (0-10); HRT = hormone replacement therapy; SD = standard 
deviation; PM = post-menopausal 
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Table 2. Comparison between patients with Burning Mouth Disorder (n=8) and controls 
(n=8) regarding the psychophysical data. 
Psychophysical 
Measures 
Patients Mean 
t-scores ± SD 
Controls 
Mean t-
Scores ± SD  
t-value p-value 
Thermal Pain 
Threshold (oC) 45.4 ± 4.8 47.4 ± 2.6 -1.04 .322 
Test 
Temperature 
Applied During 
the fMRI Session 
(oC) 
47.6 ± .9 48.1 ± .8 -1.14 .273 
Pre-fMRI Pain 
Rating (0-10) 5.6 ± 1.9 5.3 ± 1.7 .43 .677 
Post fMRI Pain 
Rating (0-10) 7.1 ± 1.4 5.8 ± 1.8 1.75 .101 
SD = standard deviation 
 
 
 
Table 3. Comparison between patients with Burning Mouth Disorder (n=8) and controls 
(n=8) regarding the SCL-90 subscales 
SCL-90R 
Subscales 
Patients Mean 
t-scores ± SD 
Controls Mean 
t-scores ± SD t-value p-value 
Somatization 61.6 ± 13.2 47.1 ± 13.1 2.21 .044 
Obsessive 
Compulsive 64.3 ± 10.5 53.3 ± 12.1 1.86 .083 
Interpersonal 
Sensitivity 60.0 ± 10.6 49.9 ± 7.7 2.19 .046 
Depression 58.3 ± 10.1 52.6 ± 10.5 1.05 .313 
Anxiety 59.9 ± 8.7 48.0 ± 10.7 2.41 .030 
Hostility 52.5 ± 9.6 52.0 ± 14.0 0.08 .935 
Phobic Anxiety 51.9 ± 9.8 46.9 ± 8.1 1.11 .285 
Paranoid 
Ideations 55.3 ± 10.8 46.3 ± 8.1 1.89 .080 
Pscychoticism 56.4 ± 11.8 53.5 ± 10.4 .517 .613 
SD = standard deviation 
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Table 4. Comparison between patients with Burning Mouth Disorder (n=8) and controls 
(n=8) regarding the BDI and STAI scores 
Test-Scores 
Patients 
Mean Scores 
± SD  
Controls 
Mean Scores 
± SD 
t-value p-value 
BDI 12.5 ± 13.1  7.4 ± 7.1 .98 .346 
State Anxiety  40.6 ± 13.7 29.8 ± 10.6 1.78 .097 
Trait Anxiety  43.0 ± 13.3  37.3 ± 12.8 .88 .392 
BDI = Beck Depression Inventory; STAI = State Trait Anxiety Inventory; SD = standard deviation 
 
5.2. Functional MRI Data Analysis  
5.2.A. Individual Group Analysis 
Statistical maps were constructed and analyzed for the BMD group and the 
control group individually. Voxels in which significant differences in the fractional signal 
change were observed (Z=3.0; p< 0.005) are shown in figure 7 for the BMD and figure 8 
for the control subjects. The maps display activation in areas that include the ACC 
(BA32/24), the right and left pre-central gyrus, the right post-central gyrus, the right and 
left thalamus, the right insula, the right medial frontal gyrus, the right middle frontal 
gyrus, the right and the left inferior parietal lobule, right and left precuneus and 
cerebellum. The left lingual gyrus and the left posterior cingulate gyrus were activated in 
volunteers but not in patients.  
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Figure 7. Activation map of the BMD group (n=8) 
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Pre-central gyrus 
 
Figure 8. Activation map of the control group (n=8) 
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5.2.B. Between Group Analyses 
5.2.B.1. Qualitative Differences 
Statistical comparison (t-test) between the BMD and control group’s activation 
maps revealed significant differences in the ACC (BA32/24) and bilateral thalamus. In 
addition, we detected differences in the following areas: left lingual gyrus, left 
precuneus, right precuneus, right middle frontal gyrus, right pre-central gyrus and right 
inferior semilunar lobule of the cerebellum. The activation maps corresponding to the 
above mentioned differences are presented in figure 9. The ACC (BA32/24) and the 
right and left precuneus showed greater fractional signal change in patients than normal 
volunteers. In the remaining areas where a significant difference was detected there 
was less pronounced fractional signal change in patients than in controls (Table 5). 
 
Figure 9. Activation map of the comparison between BMD group (n=8) and control 
group (n=8) 
 
BMD Group vs. Control Group 
Control > BMD 
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5.2.B.2. Quantitative Differences 
As a general measurement of brain activation, we calculated the total volume of 
activation for each group of subjects (BMD and controls) using a cluster size threshold 
of 1000 µl (approximately 27 voxels) and voxel connectivity radius of 2mm. This 
analysis revealed that the BMD group (24432 µl) displayed less volumetric brain activity 
when compared to the control group (92528 µl). To better categorize this discrepancy in 
the amount of activation between the two groups we also compared the two groups 
taking into account the total number of separate clusters above the 1000 µl threshold in 
each group. The BMD group cluster analysis revealed 4 large clusters of activity while 
the control group had 10 clusters. Tables 6 and 7 display the Talairach coordinate for 
the center of mass as well as the size of each of the detected clusters in the BMD group 
and control group respectively. It is important to notice that the total volume of activation 
displayed in Tables 6 and 7 will be slightly smaller than the total volume of activation 
reported above. This is because during inspection of the statistical maps we detected a 
large cluster of activity embracing three distinct brain regions in the statistical maps of 
the control group. This large cluster in reality represented three separate clusters 
connected by a small number of voxels. We decided to erode the data in order to 
separate these three clusters. For a fair comparison the activation maps of both groups 
were eroded. This was done by eliminating the voxels of activity that were marginal to 
the main large initial cluster. By comparing the location of the center of mass from the 
patient group versus the control group we observed that the location of 3 clusters were 
common to both patients and controls. The common activation areas were: right insula, 
right medial frontal gyrus and right inferior parietal lobule. A large cluster involving the 
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cingulate gyrus/BA32 was found exclusively in the patient group.  Clusters located at 
the right cerebellum, right anterior cingulate gyrus/BA 10, left cerebellar tonsil, right and 
left thalamus, right inferior frontal gyrus and right middle frontal gyrus were unique to the 
control group. 
 
Table 5. Areas of differential activation between BMD patients (n=8) and pain-free 
volunteers (n=8). 
Talairach Coordinate 
(mm) 
Mean Fractional 
Signal Change 
(%)  Anatomical Location 
x y z BMD Control 
z-score 
R ACC BA32/24 2.5 23.5 31.5 .23† .04 -3.029  
L Thalamic Medial Dorsal 
Nucleus -13.5 -20.5 11.5 .10 .31† 3.024  
R Thalamic Medial Dorsal 
Nucleus 8.5 -17.5 11.5 .18 .33* 2.044  
R Middle Frontal Gyrus 37.5 23.5 31.5 -.02 .17* 2.527  
R Pre-central Gyrus 36.5 3.5 36.5 .02 .16 * 2.143 
L Lingual Gyrus -18.5 -64.5 0.5 -.05 .32* 2.267  
L Precuneus -20.5 -65.5 19.5 .37* .02 -2.022  
R Precuneus 9.5 -68.5 19.5 .15‡ -.26 -4.479  
R Cerebellar Inferior 
Semilunar Lobule 5.5 -67.5 -34.5 -.06 .44† 3.283  
BMD = burning mouth disorder; R = right side ; L = left side ; BA = Brodmann area ; * p<0.05 ; † 
p<0.005; ‡ p<0.001  
 
Table 6. Location and size of the detected clusters of activity in the patient group 
Talairach 
coordinates Cluster # 
x y z 
Anatomical Location 
Cluster 
volume 
(µl) 
1 4.1 24.3 30.7 R Cingulate Gyrus / BA 32 2344 
2 43.2 8.2 4.6 R Insula* 2232 
3 1.2 -3.9 53.2 R Medial Frontal Gyrus* 1744 
4 37.4 -39.6 44.9 R Inferior Parietal Lobule* 1264 
R = right side; L = left side; BA = Brodmann area; * = areas activated in both patients and controls 
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Table 7. Location and size of the detected clusters of activity in the control group 
Talairach 
coordinates Cluster # 
x y z 
Anatomical Location Cluster volume (µl) 
1 14.4 -58.1 -26.8 R Cerebellum 10344 
2 4.8 53.1 -0.4 R Anterior Cingulate Gyrus / BA 10 5024 
3 -26.2 -50.1 -32.1 L Cerebellar Tonsil 3512 
4 -12.9 -17.5 13.6 L Thalamus 2344 
5 28.3 3.4 12.4 R Insula * 2080 
6 0.2 37.7 30.2 R Medial Frontal Gyrus* 1928 
7 9.7 -13.5 12.4 R Thalamus 1912 
8 40 3.1 32 R Inferior Frontal Gyrus 1800 
9 33.1 30.7 29.8 R Middle Frontal Gyrus 1096 
10 50.2 -41.9 31.5 R Inferior Parietal Lobule* 1000 
R = right side; L = left side; BA = Brodmann area; * = areas activated in both patients and controls 
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6. Discussion 
To the best of our knowledge, the present report is the only fMRI study with BMD 
patients. This study demonstrated significant brain activation (p<0.005) in both BMD 
patients and normal controls in pain related areas following thermal noxious stimulation. 
The activation pattern was similar to that found in earlier fMRI studies involving painful 
thermal stimulation of non-trigeminal [37, 39, 48, 63] and trigeminal sites [73]. The same 
activation pattern has also been observed with painful heat stimulation of the non-
dominant arm in PET studies [52, 128]. The activated brain regions have been 
implicated in the processing of different dimensions of the pain experience. Both groups 
displayed significant changes in BOLD signal (p<0.005) at the SI and thalamus. These 
two structures are likely related to the sensory-discriminative aspect of the pain 
experience. We also observed significant (p<0.005) activation in the cingulate gyrus. 
This structure is thought to be mediating the affective-motivational portion of pain. 
Activation was further observed in the cerebellum, inferior parietal lobule, frontal gyrus 
and pre-central gyrus. These regions are associated with the motor response to painful 
stimulation.  Finally, there was activation in the insula and frontal gyrus, both of which 
are implicated in the processing of pain related memories.[28, 48, 129]  The activation 
of these brain regions in our study population indicates that our thermal stimulus 
protocol is a reliable technique of thermal stimulation for the trigeminal nerve during 
fMRI acquisition as demonstrated by de Leeuw (2001).[73] In both groups the activation 
of the post-central gyrus (SI) occurred in the vicinity of the area that represents the 
face.[74] 
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The primary objective of this study was to demonstrate differences in the location 
and extension of activation between BMD patients and normal volunteers. We 
demonstrated that BMD patients process thermal painful stimulation quantitatively and 
qualitatively different than normal pain-free age and gender matched control subjects. It 
is worth mentioning that there were no differences in the subjective experience of pain, 
or in the temperatures used to create such experience.  For this reason, brain activation 
discrepancies found in this study cannot be explained in terms of the subjective 
experience of pain but may reflect true functional disparities between the two groups. 
On the other hand, our small group size may have precluded us to find true differences 
with regard to these variables. In order to characterize these differences, we chose to 
analyze the data in terms of the magnitude of fractional BOLD signal change on a voxel-
to-voxel basis, as well as in terms of the total volume of brain activation at a threshold of 
1000µl.   
 
6.1. Qualitative Differences in Brain Activation Between Patient and Controls 
In terms of the locations of significant brain activation, we were able to show that 
the BMD patients had greater BOLD signal change in the right ACC (BA24/32) and 
bilateral precuneus than did normal controls. ACC hyperactivity has been demonstrated 
in other neuroimaging studies involving chronic neuropathic pain conditions [16, 19, 21, 
22, 69]. It is important to note that there are fundamental differences between this and 
the above mentioned studies. Firstly, most of these previous studies used PET as their 
imaging technique. Secondly, the findings of such studies reflect changes in activation 
from a painful status to a pain-free state in the same group of patients. Our study 
 
 
47
involves two distinct groups of subjects and explores differences in the processing of 
transient painful stimuli delivered to the division of the trigeminal nerve that is 
supposedly mediating the chronic pain condition. Therefore, our data merely suggest 
that BMD patients have a dysfunctional ACC (BA32/24) while the other studies, in light 
of their methods, more directly imply that the ACC (BA32/24) plays a role in the 
pathophysiology of the chronic pain condition. Since the ACC has also been implicated 
in the processing of anxiety, [34] it may be argued that the difference of activation at the 
ACC reflects greater anxiety levels in the patient group as shown by the differences on 
the SCL-90 anxiety subscale between the BMD and normal controls. The effects of 
psychological variables such as anxiety, somatization and interpersonal sensitivity, 
which have been shown to be elevated in our patient population, must always be taken 
into account in brain imaging studies. 
The precuneus was another area where patients displayed a greater magnitude 
of activation when compared to the control subjects. Precuneus activation has been 
linked to a variety of CNS processes. It appears that this region of the brain is a 
multimodal association area [130] and possesses motor and sensory functions. For 
example, precuneus activation has been shown during volitional swallowing [131, 132], 
locomotor-related imagery [133] and painful somatosensory hallucinations. [134] Most 
importantly, precuneus has been activated during mechanical muscle hyperesthesia in 
the orofacial region [71]. It is possible that precuneus hyperexcitability is implicated in 
the pathophysiology of BMD, however due to its dynamic functional characteristics it is 
very difficult to determine its exact role with the presently available data. 
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The thalamus was found to be differently activated in patients as compared to 
controls. Generally, thalamic responses to painful stimuli reflect discriminative and 
attentional networks of pain processing mechanisms.[28] This study revealed that 
control subjects had significantly greater bilateral BOLD signal changes in the thalamus 
than BMD patients This implies that the thalamus in BMD patients may be hypoactive. 
The area of activity within the thalamus appeared to involve the dorsal medial nucleus 
as well as the ventral lateral nucleus of the thalamus. However spatial smoothing of 
fMRI data makes it extremely difficult to draw accurate conclusions about the activation 
of such small regions of the brain. The finding of thalamic hypoactivity is in agreement 
with other neuroimaging studies that demonstrated thalamic hypofunction in patients 
suffering from chronic pain conditions.[20-22, 64] Thalamic hypoactivity is unlikely 
related to acute pain states, because thalamic hyperactivity has been demonstrated 
during acute pain conditions such as angina pectoris [135], cluster headache[17] and 
dental pain.[115]. Neuroimaging studies have shown significant increases in thalamic 
activity following procedures that led to cessation of chronic pain. These procedures 
include cordotomy for cancer pain [58], anesthetic blocks [21] and motor cortex 
stimulation for neuropathic pain [136]. Therefore, in chronic pain conditions, it is 
hypothesized that thalamic hypofunction is very likely a result of persistent, 
spontaneous chronic pain input. The idea that a hypofunctional thalamus may be 
directly related to the pathophysiology of neuropathic pain is supported by studies in 
which thalamic stimulation provides pain relief [59, 60, 137]. Kupers et al. reported a 
case of a patient with chronic orofacial neuropathic pain that was successfully treated 
by thalamic stimulation. They showed with PET that following thalamic stimulation and 
 
 
49
subsequent pain relief, there was an increase in rCBF in areas of the brainstem that are 
often linked with descending inhibition of pain, such as the periaqueductal gray matter. 
Consequently, it is thought that the hypofunctional thalamus does not allow for 
adequate descending inhibition during chronic pain states. The present findings indicate 
this may be the case for BMD as well. 
This research showed that the control group also had significantly greater BOLD 
signal increases in the right middle frontal gyrus, right pre-central gyrus, right cerebellar 
inferior semilunar lobule and left lingual gyrus as compared to the BMD group. The right 
middle frontal gyrus is the supplementary motor area (SMA) and it has shown to be 
activated in other functional neuroimaging studies of pain [49, 138, 139]. Presumably, 
the SMA is involved in the planning and readiness for a withdrawal response secondary 
to pain.[128] The pre-central gyrus is the primary motor cortex and it has also displayed 
rCBF changes during painful stimulation. The activation of this area is primarily related 
to volunteer motor activities; however, in neuroimaging pain studies it is postulated that 
its activation may also reflects withdrawal reaction or movement refrain [28]. Activation 
of the cerebellum has been described in neurofunctional studies of pain.[17, 37, 43, 65, 
71, 72, 138, 140] It is hypothesized that the cerebellum is involved in motor planning, as 
well as in the cognitive, affective and nociceptive processing of pain. Recent evidence 
reinforces the premise that the cerebellum is in fact involved in pain intensity encoding. 
[141] Despite the similar subjective experience between the two groups the control 
group displayed greater activation in areas responsible for the processing of motor 
response, for instance cerebellum, SMA and pre-central gyrus. Interestingly, stimulation 
of motor cortex has been shown to relieve neuropathic pain.[136] Given the diminished 
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response in BMD patients compared to controls, it could be postulated that these 
cortical areas, primarily involved in motor function, also play a significant role in 
descending inhibitory processes. 
The lingual gyrus is part of the visual cortex; it is located within the occipital lobe. 
Its function has been linked to the visual perception of motion [142, 143]; it has been 
implicated in semantic language processing [144] and it has also been reported as a 
site of processing aversive visual stimuli [145, 146]. In the present study, activation of 
the lingual gyrus in the absence of a specific visual task is interesting. The relationship 
between the lingual gyrus and pain processing is not understood.  
In summary, this study showed significant qualitative differences in brain 
activation patterns between BMD and normal controls. These differences are likely 
related to a dysfunctional brain network present in BMD patients. These findings will be 
the foundation for the development of a working hypothesis regarding BMD 
pathophysiology. 
 
6.2. Quantitative Differences in Brain Activation Between Patient and Controls 
In terms of extent of brain activation, the present study showed that normal 
volunteers had greater total volume of brain activation in response to the painful 
stimulation than BMD patients. Additionally, our cluster analysis (size threshold of 
1000µl) revealed that volunteers were able to activate more brain regions than did BMD 
patients. Whereas only four clusters of activation were detected in patients, 10 were 
detected in the normal volunteers. While a similar analysis methodology was used in a 
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neuroimaging study with fibromyalgia patients, contrasting results were found. [64] The 
study reported that fibromyalgia patients showed a greater number of activated brain 
areas than controls. The authors discussed their data in terms of cortical and subcortical 
augmentation of pain processing in fibromyalgia patients. The increased number of 
activated brain regions found by Gracely et al. may be related to several factors. Firstly, 
they used the same stimulus intensity for all participants. Since fibromyalgia patients 
have lower pressure pain threshold they produced different subjective pain ratings 
between patients and volunteers. In our study we were able to create the same 
subjective pain experience with equal stimulus intensities. Secondly, our study used 
thermal stimulation of the trigeminal nerve, while they used mechanical stimulation 
(pressure) to the left thumb nail. Thirdly, the difference between our study and Gracely 
et al.’s may be secondary to the fact that fibromyalgia is a widespread pain and not a 
focal and localized condition such as BMD. Our findings of diminished number of 
clusters and total volumetric activity coupled with the previously mentioned qualitative 
discrepancies in BMD patients as compared to normal controls may be interpreted as 
representing impaired brain network connectivity dynamics essential for inhibitory 
control. Thayer and Friedmann (2002) [70] reported that the behavior of living systems 
may be defined as a self-organizing dynamic system. Moreover, they suggested that 
inhibitory processes allow these systems to efficiently function in the face of changing 
environmental demands. They also mention that the process of sensitization does not 
always imply overall hyperactivity but it may be defined as a loss of inhibitory neural 
processes leading to maladaptive activation of fewer brain pathways. Our findings imply 
that BMD patients process acute thermal stimulation less dynamically than do normals. 
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Our theory is that patients with BMD have a diminished inhibitory control of sensory 
experiences and as a consequence of such they may be more likely to experience intra-
oral proprioceptive information as burning pain. This theory of overall brain hypofunction 
in BMD is supported by other studies where hypoactivity of the nigrostriatal 
dopaminergic system was documented in BMD patients.[109, 111] It is possible that, 
because of the multiple connections that exist between thalamus and the basal ganglia, 
the thalamic hypofunction shown in BMD patients is primarily responsible for the 
hypoactivity of the nigrostriatal dopaminergic system. It is also possible that the 
hypofunctional thalamus is playing a crucial role in diminishing brain connectivity 
dynamics. Hypofunction of the thalamus has been described in other chronic 
neuropathic pain conditions and it may not be an exclusive feature of BMD.[21, 58] In 
summary, these findings suggest quantitative differences in brain function between 
patients with BMD and normal volunteers. These results support the development of a 
working hypothesis that BMD may be a consequence of diminished brain dynamics that 
lead to the perception of burning in the intra-oral tissues. In fact, the hypothesis of 
overall brain hypofunction is an alternative explanation for why systematic literature 
reviews describe cognitive behavioral therapy among the most efficacious treatment 
modalities for BMD.[147, 148] Based on our findings, we might  postulate that cognitive 
behavioral therapy promotes brain dynamics leading to relief of the burning sensation. It 
has been shown with PET and fMRI that cognitive behavioral therapy and relaxation 
techniques are capable of changing brain activation patterns as well as sympathetic 
activity [149, 150] The cognitive engagement that comes as a consequence of cognitive 
behavioral therapy and relaxation may stimulate critical regions of the brain, such as the 
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cerebellum [150] just enough to re-establish inhibitory processes that have not been 
functioning adequately. 
It is very difficult to draw conclusions regarding differences in specific areas of 
the brain and how they may relate to the pathophysiology of BMD. Despite the fact that 
we found areas that were differentially activated, trying to assign a specific function to a 
defined area of the human brain is very difficult as the brain involves multiple interacting 
structures. The processing of sensory information by the CNS is very dynamic; and it is 
possibly very different from individual to individual. It is important to note that our data 
support our hypothesis that BMD patients would display brain activation patterns that 
are similar to those reported in patients with chronic neuropathic pain (hypofunctional 
thalamus, hyperfunctional ACC (BA24/32)). We also postulate that brain areas primarily 
involved in motor tasks may be important for the descending inhibitory system and may 
be playing a key role in the pathophysiology of BMD.    So, the question becomes how 
can one behaviorally “activate” the thalamus and other CNS sites so it can do their 
behavioral inhibitory work?  This should be the focus of future investigations in this 
newly emerging field. 
 
6.3 Future Research Directions 
Future studies should investigate if the same fMRI paradigm reveals similar 
patterns of brain activation in other focal chronic neuropathic pain conditions in the 
orofacial region, for example, continuous neuropathic pain.  Similar studies with 
musculo-skeletal chronic pain conditions, for instance masticatory muscle pain 
disorders, would also be warranted. These studies may help determine if the activation 
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patterns described above are unique features of BMD, other focal neuropathic pain 
conditions, or just any chronic orofacial pain state.  
Future studies should also investigate the effects that cognitive behavioral 
therapy, diaphragmatic breathing and other behavioral strategies have in brain 
activation patterns. Special attention should be given to how these behavioral 
techniques modulate thalamic activity. Our working hypothesis of a hypofunctional brain 
in BMD patients and the current evidence that cognitive behavioral therapy is an 
effective treatment for this condition[147, 148] lead us to believe that these behavioral 
approaches could potentially correct the maladaptive changes in brain function. 
In light of its invasiveness, thalamic and other CNS stimulators may not be the 
primary focus of investigation for BMD. However, studies involving such devices would 
certainly help clarifying the implications of brain hypofunction in BMD. Thalamic 
stimulators have been used in the treatment of neuropathic pain conditions [59, 151] 
Stimulation of thalamus and other CNS sites (motor cortex, spinal cord) [14, 136, 152] 
increased activity in the different brain regions and significantly decreased persistent 
neuropathic pain conditions.  Finally, studies on the role of primarily motor function 
related brain areas in the descending inhibition processes are also warranted.  
 
6.4. Study Limitations 
 The small sample size and consequent diminished statistical power put in 
question the reliability of our psychophysical data (potential for type II error). In terms of 
fMRI statistical analysis our sample size appears to be adequate. It would have been 
better if we had recruited a larger number of patients with BMD from which 
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psychophysical data could be collected. After collection of psychophysical data, a 
smaller sample of these patients could be randomly assigned to undergo fMRI 
scanning. This alternative design would provide us more power regarding our 
psychophysical conclusions. It is important mentioning that our psychophysical data 
analysis was in agreement with other larger studies with BMD patients.[101, 153] 
Another point that needs to be taken into account, as a limitation of this study, is 
that there was potential bias in the selection of patients. Patients who were taking 
medications that interfered with brain functioning, such as, antidepressants or 
benzodiazepines; and who were unable to discontinue such medication were excluded 
from this study. It is possible that only patients with milder cases of BMD were included 
in our patient sample. 
The large age range of our patient population and normal volunteer group could 
have serious implications in our fMRI data analysis. It is well known that the brain 
atrophies with age.[154] This could account for a large variability in brain anatomical 
features and may have influenced our data in a negative way during the normalization 
process and construction of three dimensional statistical maps. The tight matching 
criteria of our study should have made this issue less problematic.  
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7. Summary 
 
 To the best of our knowledge, the present study is the only fMRI study 
concerning BMD. This research’s results showed that BMD patients possess different 
patterns of brain activation compared to normal volunteers, as it relates to an acute 
thermal stimulation of the trigeminal nerve. These differences were qualitative and 
quantitative It was demonstrated that BMD patients have brain activation patterns 
similar to those reported in other neuropathic pain conditions.. When compared to 
volunteers, patients with BMD showed greater BOLD signal changes in the ACC 
BA32/24 and bilateral precuneus; and diminished BOLD signal changes in the bilateral 
thalamus, right middle frontal gyrus, right pre-central gyrus, left lingual gyrus and 
cerebellum.  It was also demonstrated that patients with BMD displayed far less 
volumetric activation throughout the entire brain compared to the control group. This 
study’s findings strengthen the theory of a central neuropathic mechanism for BMD and 
have led to the development of a theory regarding the pathophysiology of BMD as it 
relates to an overall hypofunctional and less dynamic brain.  
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